# A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

> **NCT00122239** · — · UNKNOWN · sponsor: **AHS Cancer Control Alberta** · enrollment: 13 (actual)

## Conditions studied

- Breast Cancer
- Glioma
- Prostate Cancer
- Carcinoma, Squamous Cell
- Carcinoma, Non-Small-Cell-Lung
- Head and Neck Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00122239
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-01
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122239, "A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers". Retrieved via MORVS 2026-09-30 from https://api.morvs.ai/clinical/NCT00122239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*